Submission of intimation of closure of trading window.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Novelix Pharmaceuticals has informed BSE that its trading window will be closed starting April 1, 2026, for all designated persons, their relatives, and other insiders under SEBI's Insider Trading Regulations. The window will reopen only 48 hours after the company declares its audited financial results for the quarter and year ending March 31, 2026. The date of the board meeting to consider these results will be announced separately. This is a routine regulatory compliance filing, not an indication of any insider transaction.
No direct impact on shareholders or stock price. This is a standard quarterly compliance step that signals upcoming audited results declaration, which could be a catalyst for price movement once announced.